Effects of tianeptine and mianserin an car driving skills

被引:35
作者
Ridout, F [1 ]
Hindmarch, I [1 ]
机构
[1] Univ Surrey, HPRU Med Res Ctr, Guildford GU2 5XP, Surrey, England
关键词
antidepressant; tianeptine; mianserin; car driving; brake reaction time; psychometric test;
D O I
10.1007/s002130000662
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Tianeptine is a novel antidepressant which enhances the reuptake of serotonin (5-HT). Previous studies suggest that tianeptine has a non-sedative side-effect profile, but its effects on everyday activities including car driving have not been fully explored. Objectives: To assess the effects of tianeptine an tests related to car driving performance. Method: Sixteen healthy volunteers received acute doses of tianeptine 12.5 mg and 37.5 mg, mianserin 30 mg and placebo in a double blind four-way crossover study. The effects of treatment on self assessed ratings of sedation (LARS), two valid and reliable laboratory performance measures, critical flicker fusion (CFF) and choice reaction time (CRT) and an "on-the-road" measure of one aspect of car driving performance, brake reaction time (BRT) were examined. The BRT test was administered at baseline and at 1.5, 3, 4.5 and 6 h post-dose, while LAPS, CFF and CRT were administered at baseline and at 1, 2, 4 and 5 h post-dose. For all data, the maximum change from baseline was calculated and used in the analysis. Results: Tianeptine had no measurable effect on performance, compared to placebo, on any of the variables investigated. Compared to placebo, mianserin was shown to lower CFF thresholds (P=0.01), increase reaction times on both the CRT (P=0.001) and the BRT (P=0.01) tests and was subjectively rated as more sedative than placebo (P=0.01). Conclusion: The apparent lack of counter-therapeutic side-effects produced by an acute dose of tianeptine suggest that it may be a suitable antidepressant for use in an ambulant population.
引用
收藏
页码:356 / 361
页数:6
相关论文
共 38 条
[1]   Association of road-traffic accidents with benzodiazepine use [J].
Barbone, F ;
McMahon, AD ;
Davey, PG ;
Morris, AD ;
Reid, IC ;
McDevitt, DG ;
MacDonald, TM .
LANCET, 1998, 352 (9137) :1331-1336
[2]  
COHEN RM, 1982, ARCH GEN PSYCHIAT, V39, P593
[3]  
Costafreda A, 1997, AGENDA, V35, P24
[4]   THE PSYCHOPHARMACOLOGICAL EFFECTS OF REPEATED DOSES OF FLUVOXAMINE, MIANSERIN AND PLACEBO IN HEALTHY-HUMAN SUBJECTS [J].
CURRAN, HV ;
LADER, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (05) :601-607
[5]   THE USE OF ANTI-DEPRESSANTS AND BENZODIAZEPINES IN THE PERPETRATORS AND VICTIMS OF ACCIDENTS [J].
CURRIE, D ;
HASHEMI, K ;
FOTHERGILL, J ;
FINDLAY, A ;
HARRIS, A ;
HINDMARCH, I .
OCCUPATIONAL MEDICINE-OXFORD, 1995, 45 (06) :323-325
[6]  
DalPozzo C, 1997, HUM PSYCHOPHARM CLIN, V12, P337
[7]   ACTION OF TIANEPTINE ON FOCALIZATION OF ATTENTION IN CAT [J].
DELAGRANGE, P ;
BOUYER, JJ ;
MONTARON, MF ;
DURAND, C ;
MOCAER, E ;
ROUGEUL, A .
PSYCHOPHARMACOLOGY, 1990, 102 (02) :227-233
[8]  
DELALLEAU B, 1988, CLIN NEUROPHARMACOL, V11, pS83
[9]  
FAIRWEATHER DB, 1993, HUM PSYCHOPHARM CLIN, V14, P325
[10]  
FAIRWEATHER DB, 1999, HUM PSYCHOPHARM CLIN, V8, P41